| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $45.3M | — | +1232.4% |
| R&D Expense | $197K | -91.9% | -98.3% |
| SG&A Expense | $1.2M | -63.1% | -76.2% |
| Operating Income | $43.8M | +858.3% | +433.3% |
| Income Tax | $0 | — | — |
| Net Income | $44.7M | +557.5% | +452.0% |
| EPS (Basic) | $1.07 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $2.8M | +38.9% | -89.7% |
| Current Assets | $5.9M | +36.7% | -82.8% |
| Total Assets | $6.6M | +30.8% | -84.4% |
| Current Liabilities | $6.8M | -23.9% | -35.5% |
| Total Liabilities | $7.4M | -85.5% | -86.0% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$14.1M | — | — |
| Capital Expenditures | $0 | — | — |
| Investing Cash Flow | $687K | — | — |
| Financing Cash Flow | -$1.8M | — | — |
| Free Cash Flow | -$14.1M | — | — |
| +445.2% |
| EPS (Diluted) | $1.07 | +565.2% | +445.2% |
| -$867K |
| +98.1% |
| +92.2% |